Paul Richard Crocker,Bjoern Biedermann,David Bowen
申请号:
US12884120
公开号:
US08394382B2
申请日:
2010.09.16
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.